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Abstract
Fundamental quality, safety, and cost problems have not been resolved by the increasing digitization of health care. This digitization
has progressed alongside the presence of a persistent divide between clinicians, the domain experts, and the technical experts,
such as data scientists. The disconnect between clinicians and data scientists translates into a waste of research and health care
resources, slow uptake of innovations, and poorer outcomes than are desirable and achievable. The divide can be narrowed by
creating a culture of collaboration between these two disciplines, exemplified by events such as datathons. However, in order to
more fully and meaningfully bridge the divide, the infrastructure of medical education, publication, and funding processes must
evolve to support and enhance a learning health care system.
(J Med Internet Res 2016;18(12):e325)   doi:10.2196/jmir.6400
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Introduction
The US Agency for Healthcare Research and Quality (AHRQ)
was established in 1989 in response to an Institute of Medicine
(now the National Academy of Medicine) report that pointed
out “escalating healthcare costs, wide variations in medical
practice patterns, and evidence that some health services are of
little or no value” [1]. More than 25 years later, there has been
surprisingly, perhaps even shockingly, little progress in these
three areas. Quality of care, as would be reflected by the
universal provision of standardized, evidence-based, and truly
indicated care, has not improved to the degree one would have
hoped. Similarly, while medical safety and errors have also
come increasingly into the awareness of the medical system
over that 25-year time period [2], advances in these areas have
been slow, hard won, and unsupported by the kinds of smart,
data-driven engineering designs that have gone into other
domains.
Recent increases in computing power and data storage have
resulted in an entirely new field involving the analysis of
digitally archived information to acquire new knowledge: data
science. While quality of care has largely been defined by
clinical trials and expensive prospective studies, the application
of data science to the clinical domain has the opportunity to
dramatically increase the speed at which knowledge is generated
and the breadth of questions that can be answered. The answers
given are of particular interest when the research would
otherwise be impractical, one such example being the
comparison of an augmented treatment with a small effect size
(normally requiring a prohibitively large prospective cohort).
Data science has the opportunity to inform clinical decision
making more directly as well, forecasting the occurrence of
relevant clinical phenomena such as physiologic deterioration,
diagnosis, medication adherence, or organ rejection. Machine
learning, a field that was nascent in 1989 when the AHRQ was
established, has now become ubiquitous and informs aspects
of our everyday life from search queries to optimal routes. In
the decade preceding the publication of the Surviving Sepsis
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Campaign guidelines [3], there was a significant increase in the
number of publications that evaluated the use of machine
learning in decision support and prognostication in sepsis (Figure
1).
The interest in applying machine learning to clinical practice is
increasing, yet the practical application of these techniques has
been less than desirable. Practitioners continue to make
determinations in a technically unsupported and unmonitored
manner due to a lack of high-quality evidence or tools to support
most day-to-day decisions, and as a result the rate of diagnostic
errors by individual practitioners is unacceptably high [4].
There is a persistent gap between the clinicians required to
understand the clinical relevance of the data and the data
scientists who are critical to extracting useable information from
the increasing amount of health care data that are being
generated. In this paper, we focus on the divide between the
data science and health care silos, and posit that the lack of
integration is the primary barrier to a data revolution in health
care. We first discuss published literature that supports the
existence of this divide, and then we present recommendations
on how to bridge the gap between practicing clinicians and data
scientists.
Figure 1. PubMed search results for ("sepsis"[All Fields] OR "septic"[All Fields]) AND ("machine learning"[All Fields] OR "data analysis"[All Fields]
OR "data science"[All Fields] OR "engineering"[All Fields] OR "computing"[All Fields] OR "prediction"[All Fields]) AND ("2002/01/01"[PDAT] :
"2016/12/31"[PDAT]).
The Divide
In both the practice and research arenas, there exists a divide
between scientists and engineers on the one hand and, on the
other, the clinicians who are most familiar with the exigencies
and uncertainties that define and constrain the practice of
medicine. There are several reasons for the development of this
situation. Until recently, there have simply been very limited
sources of data available to perform research such as the
determination of comparative effectiveness, cost analysis, and
the elucidation of treatment effect heterogeneity. Further, there
has been a lack of strong motivation (ie, little, to no, to negative
financial incentives; a lack of substantiating research; and strong
individual and industry inertia and resistance) to reduce wasteful
and sometimes harmful practice variation, or avoid (generally
well-reimbursed) health services that are of little or no value.
In 2012, Kiri Wagstaff of California Institute of Technology’s
Jet Propulsion Laboratory published an insightful article entitled
“Machine learning that matters,” which pointed out how
disconnected much of machine learning research is from
important (and real) problems in society, including those of
health care [5]. With the aim of refocusing efforts on topics that
matter, Wagstaff proposed several “Impact Challenges” that tie
machine learning to real-world outcomes, such as saving a
human life or making significant financial savings through
improved decision making. In a 2014 special issue of the journal
Machine Learning [6], Rudin and Wagstaff explored the
connection between machine learning research and its
broader-world applications in more detail, and explicitly
emphasized the importance of interdisciplinary collaboration
for development of impactful research. While there is a clear
need for machine learning in a variety of practical applications,
the authors suggested that lack of enthusiasm in top venues to
promote such work creates a “contradictory situation” that holds
it back. Such situations serve to reinforce the health data divide.
Bridging the Divide
Recommendation 1: Collaboration
Given the definition of the problem, the most obvious solution,
and yet the most challenging one, is encouraging collaboration
between data scientists and clinicians. The incorporation of
statistics into clinical research in the past 50 years and the rise
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of the biostatistician can act as a template from which the
community can learn. The role of a biostatistician in biomedical
research has become collaborative over time, at least partly due
to the history and traditions of the discipline. An important event
in this history in the United States was the passage of the 1962
Kefauver-Harris amendments to the Federal Food, Drug, and
Cosmetic Act, which established in a preliminary form the
method by which drugs are evaluated by the Food and Drug
Administration today [7]. The act itself mandated proof of
efficacy for new drugs, which had not been required before its
signing into law. This piece of legislation and the ensuing events
in the following two decades brought statisticians into close
contact with clinician investigators, who now needed the
statistician’s expertise to design, analyze, and report their study,
and effectively established the tradition of collaboration between
biostatisticians and clinician scientists seen to this day.
Can this process be accelerated between data scientists and those
immersed in the practice of medicine? At the novel Icahn
Institute for Genomics and Multiscale Biology at Mount Sinai
Health System in New York, more than 300 people were hired
to staff the new institute, with backgrounds across hardware
design, big data computing, gene sequencing, and bioinformatics
[8]. By linking this talent with disease centers within Mount
Sinai, and using the tools of machine learning and predictive
modeling (elements of big data), scientists have already
published on inflammatory models in common-variant
Alzheimer disease [9] and are taking a closer look at one of the
most complex and biodiverse cell populations in the human
body, the gut microbiome, which may be responsible for far
more of the body’s homeostasis than previously realized [10].
Bridging the divide may be facilitated by instilling researchers
with a greater appreciation of the benefits offered through
collaboration with colleagues of complementary disciplines.
Two papers published in Advances in Physiology Education, a
journal of the American Physiological Society, call for changes
in medical education to do so, with the aim of closing the
knowledge gap between engineers and physicians [11,12].
Recommendation 2: Education
Medicine has clumsily entered its digital age via the back door:
vast and costly electronic medical records systems have been
implemented largely without careful and planned consideration
for their impact on the entire health care system, including
education, practice, workflows, and research. Education and
practice systems have not taken this new digitized world into
full account, and consequences include students who are
unprepared for their digital futures, very unhappy physicians
stuck behind computer screens selecting seemingly endless
items in reams of dropdown lists, and the unconscious loss of
many opportunities for improvements in practice and research.
It is time, even if a bit tardy and somewhat less than proactive,
to acknowledge and address this transition of medicine from
paper to computer, from opinion and experience to evidence,
and from memory to search engines.
Previous reports have demonstrated a deficit in knowledge of
clinicians and even clinician scientists relating to statistical
methods and their applications to clinical data, including the
data used in practice [13,14]. There appears to be little
knowledge of, and seemingly even less interest in, these
increasingly critical issues among most physicians. This
unacceptable awareness and training gap has prompted updates
internationally in medical curricula in order to include additional
instruction in and exposure to statistical applications and
epidemiology. However, there are inadequate numbers of
physician educators who are equipped with the knowledge in
informatics and data science required to provide even the most
basic and essential insights to junior trainees [15].
The questions then consist of who, when, how, and what do we
train? Training should focus on two groups of medical trainees:
medical students and residents. If we accept that over the next
half century there will likely be an increasing need for hybrid
skills of this nature, then there is a strong case for inclusion of
data science in the core curriculum in medical school and during
residency training [16]. An introduction to the use of digital
health records for research may provide a foundation to be able
to contribute to knowledge discovery regardless of the career
path medical students and residents eventually choose. This
should then be followed by optional courses, preferably with
practical research (eg, summer courses or internships), to further
develop these skills for those particularly interested. This latter
group is likely to form the core of future educators in this area.
Interested medical students and residents would benefit from
educational opportunities that foster cross-disciplinary working
relationships. One such experience might be the participation
in the datathons that we have previously used in our own work
to encourage collaboration [17]. The resources and insights
generated during such events may be stored and used in ongoing
collaborations and may be continually updated to provide greater
scientific rigor and insight. A final suggestion is represented by
online platforms and communities, where physicians and data
scientists could interact, discuss clinically relevant questions,
and share repositories of code and worked examples.
Perhaps most important, creating a medical culture that is aware
of and respectful of the importance and potential power of data
for supporting and improving both practice and research may
be the most important and ultimately effective element. It is
desirable that each participant in the clinical process realizes
and understands their role in the overall system of providing
reliable and robust data that they and others will subsequently
use in improving care.
Recommendation 3: Rethinking Academic Incentives
The education of medical trainees in data analysis methods and
data scientist trainees in the particular domain issues of clinical
practice and data would be a primer for future collaboration
between the two groups later in their careers. Such cooperation
could be fostered by policies on the part of academic journals
that encourage joint submissions from clinicians and data
scientists. The perceived “publish or perish” culture of academic
medicine has not much changed for the past 30 years [18] and
has led to all manner of trivialities: publishing on obscure or
irrelevant results with minimal clinical or research importance;
sectioning results into multiple manuscripts across numerous
journals; and competing for data sets (or, at least, a lack of
transparency and sharing of the same). While not a panacea for
these ills, equal authorship may ease some of the barriers to
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cooperation between researchers and perhaps result in
higher-quality publications. Big data lends itself better to
collaboration than to separation—multiple studies can be run
on the same dataset for different purposes. For instance, an
emergency department data set from Hong Kong was used both
to identify populations who are sensitive to extreme weather,
and to develop a long-term forecast for ambulance demand
through 2036 [19].
We predict that the continued success of such collaborative
models will require the recognition of equal authorship as on
par with first/last authorship as currently used by journals,
universities, and funding agencies. We argue that the impact of
the paper is more important than the individual contributions,
provided the authors will testify they each had a meaningful
role to play in the development of the final publication or
proposal. Equal authorship may not end, but could temper,
current publishing strategies where multiple, smaller, less
impactful papers are released so as to procure first/last
authorship for all members of the group—currently important
for their curricula vitae and academic standing. A next step
would be to give credit for the use of data by
counterparties—how better to validate one’s cohort than to have
other researchers use the same data for their own related (or
unrelated) research questions? Any conclusions reached by the
latter should in part be attributed to the former for their role in
generating and collating a high-fidelity data set, and that role
also recognized in academic circles. These measures would
encourage investment in big data infrastructure while also
improving the quality of “big data” conclusions.
Recommendation 4: Funding
Fostering research in a specific field and encouraging
collaboration between fields through funding is not new. Almost
20 years ago, the US National Institutes of Health (NIH)
convened a Director’s Panel on Clinical Research to address
the decline in physician investigators applying for clinical
research grants. The panel proposed a series of recommendations
to increase the funding opportunities for clinical researchers
[20]. We suggest implementing many of the same methods
today to encourage closer collaboration between clinicians and
data scientists through funding and incentives.
NIH-funded research programs are classified using activity
codes, with, for example, codes from the R series corresponding
to research grants (eg, R01, R13) and from the K series
corresponding to careers development awards. We suggest
creating a K award category for clinicians engaged in data
science similar to a K23 grant for clinicians that the Director’s
Panel on Clinical Research proposed. Providing a unique K
grant for data scientists would provide increased funding
opportunities, since K awards typically fund 40% of applicants,
unlike the R0 awards, which are more competitive and funded
at a much lower rate, usually 10%. This support is critical to
foster data science investigators during the vulnerable early
period in their career.
By restructuring study sections and adding study sections across
all the institutes exclusive to secondary analysis, grants would
increase the funding available for data science proposals that
may not otherwise obtain funding in the current structure.
Having a study section specific to secondary analysis to score
data science proposals would ensure that at least 10% of the
data science proposals are funded (and avoid competing against
primary analysis proposals, which might receive preferential
scoring). In addition, mandating a health care provider as part
of the proposal team would encourage the clinical impetus
behind the proposal.
Another example of the US federal government increasing
access to funding is the US Department of Veterans Affairs’
Big Data Scientist Training Enhancement Program, which has
been adopted by 6 pilot centers [21]. The program supports data
scientists working directly with clinician scientists on-site at a
hospital.
Conclusion
Better use of clinical data has the potential to address a number
of important, problematic, and unresolved issues in the health
care system. These include high, and perhaps excessive, costs;
unnecessary and undesirable practice variation; the improvement
of digital workflows; the universal implementation of a
reasonable, reliable, and usable version of evidence-based
medicine; the introduction of personalized and precision
medicine; quality; safety; effective communication; efficient
care coordination; and the introduction of data-driven and
-supported clinical decision making. However, the introduction
of this kind of revolution into health care inevitably involves
crossing disciplinary boundaries in a way that requires
cooperation and collaboration among a frankly diverse group
of experts in order to optimize the combined output of these
contributors. The formation of such teams requires that each
team member be more educated in the issues involved outside
of their own comfort areas. As a primarily medically oriented
group, we focus on the impact on medical training, but the
principles relate to those in nonmedical areas who need to
become sufficiently educated in clinical matters to contribute
optimally to the grand scheme. For example, how can current
advanced analytic techniques such as machine learning be best
applied to both clinical research and practice problems? Clearly,
specific kinds of clinical-technical collaborations will be
required to guide these kinds of processes and projects to
fruition.
In this paper, we have attempted to portray not just the problems,
but also potential solutions, or at least beginning approaches to
solutions, for the situation in which we find ourselves. This
situation involves a costly, complex, and massive health care
system that can well bear improvement, and a growing mound
of underutilized data that is accumulating as a result of the
accelerating digitization of medical care.
Clinicians should not feel like interchangeable cogs entering
reams of data blindly into a vast black hole of no return; data
scientists should not be discovering new knowledge and
developing predictive algorithms isolated from the domain
experts. Rather, all should see themselves as diversely necessary
components of a truly functional clinical data system that works
toward providing excellent care to individuals and populations
while working to improve all facets of that care.
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Take-Home Messages
1. Fundamental quality, safety, and cost problems have not been
resolved by the increasing digitization of health care.
2. This digitization has progressed alongside the presence of a
persistent divide between clinicians, the domain experts, and
the technical experts, such as data scientists.
3. The divide can be narrowed by creating a culture of
collaboration between these two disciplines, exemplified by
events such as datathons.
4. However, in order to more fully and meaningfully bridge the
divide, the infrastructure of medical education, publication, and
funding processes must evolve to support and enhance a learning
health care system.
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